Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection- An Analysis of the DARE-19 Randomized Controlled Trial
ViewRosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials
ViewDrivers of vildagliptin prescription for Romanian patients with type 2 diabetes, the TREND study
ViewEvaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis
ViewA Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study
ViewEfficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials
ViewLong-term effectiveness and safety of quadruple combination therapy with empagliflozin versus dapagliflozin in patients with type 2 diabetes: 3-year prospective observational study
ViewClinical diagnosis and safety of vildagliptin versus glimepiride with metformin over patients of type-2 diabetes mellitus
ViewComparison of the Efficacy of Rosuvastatin 5 mg and 10 mg in Patients of Type 2 Diabetes Mellitus With Dyslipidemia
View